# Edmund J. Lewis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/edmund-j-lewis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,203 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 71 |
| i10-index | 154 |
| Last Known Institution | NKT Therapeutics (United States) |
| OpenAlex ID | https://openalex.org/A5048492705 |
| ORCID iD | https://orcid.org/0009-0001-0323-3083 |
| Works | 231 |

## Researcher papers

- [Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes](https://scholariq.org/papers/renoprotective-effect-of-the-angiotensin-receptor-antagonist-irbesartan-in/)
- [Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/aliskiren-combined-with-losartan-in-type-2-diabetes-and-nephropathy/)
- [Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis](https://scholariq.org/papers/pharmacological-blood-pressure-lowering-for-primary-and-secondary-prevention-of/)
- [Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials](https://scholariq.org/papers/change-in-albuminuria-as-a-surrogate-endpoint-for-progression-of-kidney-disease/)
- [Independent and Additive Impact of Blood Pressure Control and Angiotensin II Receptor Blockade on Renal Outcomes in the Irbesartan Diabetic Nephropathy Trial](https://scholariq.org/papers/independent-and-additive-impact-of-blood-pressure-control-and-angiotensin-ii/)
- [Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis](https://scholariq.org/papers/age-stratified-and-blood-pressure-stratified-effects-of-blood-pressure-lowering/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Renin-Angiotensin System Studies](https://scholariq.org/topics/renin-angiotensin-system-studies/)

## Researcher university

- [NKT Therapeutics (United States)](https://scholariq.org/institutions/nkt-therapeutics-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.